National Stroke Foundation

Vistide (cidofovir)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved March 1999

Specific Treatments:

Infectious Diseases

Therapeutic Areas

General Information

Vistide (cidofovir injection) 75 mg/mL has been approved for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS.